Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pivotal bioVenture Partners China

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$65M
Portfolio companies 5
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pivotal bioVenture Partners China:
Typical Co-investors
Pivotal bioVenture Partners China is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pivotal bioVenture Partners China:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Shiji Beiguang Advertising Co -
Cedar Grove Investments Seattle, United States, Washington
Dinghongxin Asset Management China, Guangdong, Shenzhen
inpro Berlin, Berlin, Germany
J12 Ventures Stockholm, Stockholm County, Sweden
Jiade Touzi -
Juxin Ziben China, Hangzhou, Zhejiang
Medicis Capital Bayern, Germany, Munich
NO/LA Angel Network Louisiana, New Orleans, United States
Northern Film and Media England, Gateshead, United Kingdom
RITEK Corporation China, Jiangsu, Taiwan
Setouchi Kanko Kasseika Fund -
Sistema SmartTech -
SKS PE Seoul, Seoul-t'ukpyolsi, South Korea
Tri-Valley Ventures California, Pleasanton, United States
UTA Ventures Beverly Hills, California, United States
W250 Venture Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Heranova Lifesciences

Biotechnology
Health Care
Medical
$3M28 Dec 2023 Huangpu, Shanghai, China

Ablaze Pharmaceuticals

Medical
Pharmaceutical
$75M29 Nov 2021 Jingan, Shanghai, China

Arctic Vision

Biotechnology
Health Care
Life Science
$100M09 Mar 2021 Shanghai, China

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$150M08 Jan 2021 Shanghai, China

Arctic Vision

Biotechnology
Health Care
Life Science
$32M13 Jul 2020 Shanghai, China

Biopharma
Biotechnology
Medical Device
Pharmaceutical
$80M10 Jun 2019 Waltham, Massachusetts, United States

OncXerna Therapeutics

Biopharma
Biotechnology
Medical Device
Pharmaceutical
$16M07 Jun 2018 Waltham, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pivotal bioVenture Partners China?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 65M
Peak activity year 2021
Lead investments 1
Follow on index 0.29
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Heranova Lifesciences

Biotechnology
Health Care
Medical
$3M28 Dec 2023 Huangpu, Shanghai, China

Ablaze Pharmaceuticals

Medical
Pharmaceutical
$75M29 Nov 2021 Jingan, Shanghai, China

Arctic Vision

Biotechnology
Health Care
Life Science
$100M09 Mar 2021 Shanghai, China

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$150M08 Jan 2021 Shanghai, China

Arctic Vision

Biotechnology
Health Care
Life Science
$32M13 Jul 2020 Shanghai, China

Biopharma
Biotechnology
Medical Device
Pharmaceutical
$80M10 Jun 2019 Waltham, Massachusetts, United States

OncXerna Therapeutics

Biopharma
Biotechnology
Medical Device
Pharmaceutical
$16M07 Jun 2018 Waltham, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: